Docaravimab - Research Grade Biosimilar
Product Specifications
CAS Number
2247196-23-0
Swiss Prot
P03524
Accession Number
P03524
Immunogen
Mus musculus / Rabies Virus Strain ERA GP Ectodomain Epitope G-III
Clonality
Recombinant Monoclonal
Conjugation
Unconjugated
Type
Primary Antibodies, Biosimilars
Source
CHO cells
Field of Research
Other
Purification
>95%
Concentration
Batch dependent
Purity
>95%
Buffer
PBS buffer pH 7.5
Modification
None
Shipping Conditions
Blue Ice
Storage Conditions
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.
Fragment
IgG2b, Kappa
Other Product Names
DOCARAVIMAB [INN], DOCARAVIMAB [WHO-DD], IMMUNOGLOBULIN G2, ANTI- (RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL .GAMMA.2-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G2B, ANTI- (RABIES VIRUS STRAIN EVELYN-ROCKITNIKI-ABELSETH GLYCOPROTEIN ECTODOMAIN EPITOPE G-III) (MUS MUSCULUS MONOCLONAL 62-71-3 .GAMMA.2B-CHAIN), DISULFIDE WITH MUS MUSCULUS MONOCLONAL 62-71-3 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G2B-KAPPA, ANTI- (RABIES VIRUS STRAINERA (EVELYN-ROCKITNIKI-ABELSETH) GLYCOPROTEIN ECTODOMAIN EPITOPE G-III), MUS MUSCULUS MONOCLONAL ANTIBODY
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
